<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917953</url>
  </required_header>
  <id_info>
    <org_study_id>XJTU1AF-CRF-2018-003</org_study_id>
    <nct_id>NCT03917953</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrical Acupoint Stimulation for the Treatment of ADHD</brief_title>
  <official_title>Transcutaneous Electrical Acupoint Stimulation for Treating Attention Deficit Hyperactivity Disorder: A Prospective, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xian Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Transcutaneous electrical acupoint stimulation may improve attention deficit
      hyperactivity disorder (ADHD).

      PURPOSE: This randomized-controlled trial study of treating attention deficit hyperactivity
      disorder of school-aged children with transcutaneous electrical acupoint stimulation to see
      how well it works compared to sham transcutaneous electrical acupoint stimulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

      To determine whether true transcutaneous electrical acupoint stimulation(TEAS) administered
      twice weekly for 4 weeks (8 sessions) compared to sham TEAS causes a significant improvement
      in core symptoms of ADHD according to the standard enacted by the national traditional
      Chinese medicine committee and relapse rate was evaluated after a half-year follow up.

      Secondary

      To evaluate the diversity of the gut microbiota before and after 4 weeks TEAS treatment.

      To evaluate the brain activity using a NIRS system before and after 4 weeks TEAS treatment.

      To assess the safety and tolerability of TEAS in this study population.

      OUTLINE: This is a multicenter study. Patients are stratified according to study site.
      Patients are randomized to two treatment arms.

      Arm I: Patients receive TEAS twice weekly for 4 weeks . Arm II: Patients receive sham TEAS
      twice weekly for 4 weeks .

      After completion of study treatment, patients are followed up at 24 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The efficacy of transcutaneous electrical acupoint stimulation in treating ADHD: Number of active patients/(Number of active patients+Improved patient Numbers+Number of invalid patients)*100%</measure>
    <time_frame>5 weeks</time_frame>
    <description>The efficacy(%)=Number of active patients/(Number of active patients+Improved patient Numbers+Number of invalid patients)*100%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diversity changes of intestinal flora before and after TEAS treatment</measure>
    <time_frame>5weeks</time_frame>
    <description>To identify fecal bacterial taxa and their predicted gene functions by 16S rRNA marker gene sequencing (16S) in ADHD participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The higher brain functions change before and after TEAS treatment</measure>
    <time_frame>5 weeks</time_frame>
    <description>We monitored the oxy-hemoglobin signal changes of ADHD participants (6-12 years old) performing a go/no-go task by functional nearinfrared spectroscopy (fNIRS).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>ADHD</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive transcutaneous electrical acupoint stimulation therapy twice weekly for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients receive sham transcutaneous electrical acupoint stimulation therapy twice weekly for 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electrical Acupoint Stimulation</intervention_name>
    <description>Patients in the experimental group will be treated for 20 min TEAS, twice a week, for a total of 4 weeks of treatment.The same intervention was performed in the sham group (electrode patches were attached at corresponding acupointswithout electroacupuncture stimulation).
Acupoint selection: baihui (DU20), taichong (LR3), taixi (KI3).</description>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must be conform to ADHD clinical diagnostic criteria (DSM-V).

          -  Patients' ages are between 6~12 years old.

          -  An informed written consent from parents and participants

        Exclusion Criteria:

          -  Patients have a history of illness that concomitant with other mental and neurological
             disorders.

          -  Patients's IQ score are lower than 70.

          -  Patients have used antibiotic drugs for the past one month.

          -  Patients have had prior transcutaneous electrical acupoint stimulation treatment
             within the past 12 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Li, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Afflicated Hospital Xian Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lixia Zhuo, Master</last_name>
    <phone>13720418610</phone>
    <email>liyanxjtu@xjtu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xian Children's Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Li, PhD</last_name>
      <phone>13720418610</phone>
      <email>liyanxjtu@xjtu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Lixia Zhuo, Master</last_name>
      <phone>18292866500</phone>
      <email>18292866500@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016 Mar 19;387(10024):1240-50. doi: 10.1016/S0140-6736(15)00238-X. Epub 2015 Sep 17. Review.</citation>
    <PMID>26386541</PMID>
  </reference>
  <reference>
    <citation>Lee MS, Choi TY, Kim JI, Kim L, Ernst E. Acupuncture for treating attention deficit hyperactivity disorder: a systematic review and meta-analysis. Chin J Integr Med. 2011 Apr;17(4):257-60. doi: 10.1007/s11655-011-0701-7. Epub 2011 Apr 21. Review.</citation>
    <PMID>21509667</PMID>
  </reference>
  <reference>
    <citation>Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, Li N, Lu Y, Su T, Sun J, Wang J, Yue Z, Zhang W, Zhao J, Zhou Z, Wu J, Zhou K, Ai Y, Zhou J, Pang R, Wang Y, Qin Z, Yan S, Li H, Luo L, Liu B. Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA. 2017 Jun 27;317(24):2493-2501. doi: 10.1001/jama.2017.7220.</citation>
    <PMID>28655016</PMID>
  </reference>
  <reference>
    <citation>Liu Z, Yan S, Wu J, He L, Li N, Dong G, Fang J, Fu W, Fu L, Sun J, Wang L, Wang S, Yang J, Zhang H, Zhang J, Zhao J, Zhou W, Zhou Z, Ai Y, Zhou K, Liu J, Xu H, Cai Y, Liu B. Acupuncture for Chronic Severe Functional Constipation: A Randomized Trial. Ann Intern Med. 2016 Dec 6;165(11):761-769. doi: 10.7326/M15-3118. Epub 2016 Sep 13.</citation>
    <PMID>27618593</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 14, 2019</study_first_submitted>
  <study_first_submitted_qc>April 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

